A case series of eperisone-induced immediate hypersensitivity
Open Access
- 1 January 2017
- journal article
- Published by XMLink in Allergy Asthma & Respiratory Disease
- Vol. 5 (4) , 228-231
Abstract
강동윤, et al. Allergy Asthma Respir Dis. 2017 Jul;5(4):228-231. https://doi.org/10.4168/aard.2017.5.4.228Keywords
Funding Information
- Ministry of Food and Drug Safety
This publication has 11 references indexed in Scilit:
- A case of eperisone hydrochloride-induced anaphylaxis: A true type I reaction?Allergology International, 2017
- Clinical efficacy and safety of eperisone for low back pain: A systematic literature reviewPharmacological Reports, 2016
- The Basophil Activation Test Is Safe and Useful for Confirming Drug-Induced AnaphylaxisAllergy, Asthma & Immunology Research, 2016
- Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactionsNature, 2014
- Anaphylaxis caused by muscle relaxant (eperisone hydrochloride)Allergy Asthma & Respiratory Disease, 2013
- Oral Muscle Relaxant May Induce Immediate Allergic ReactionsYonsei Medical Journal, 2012
- Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trialAdvances in Therapy, 2009
- A Case of Eperisone Hydrochloride‐Induced Acute Generalized Exanthematous PustulosisThe Journal of Dermatology, 2004
- Non-pigmenting fixed drug eruption: a new case due to eperisone hydrochlorideBritish Journal of Dermatology, 2001
- Pharmacological studies on 6-amino-2-fluoromethyl-3-(O-tolyl)-4(3H)-quinazolinone (Afloqualone), a new centrally acting muscle relaxant. (II) Effects on the spinal reflex potential and the rigidity.The Japanese Journal of Pharmacology, 1982